Amundi’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267M | Buy |
3,461,129
+541,943
| +19% | +$41.7M | 0.09% | 208 |
|
|
2025
Q1 | $213M | Sell |
2,919,186
-402,011
| -12% | -$29.3M | 0.08% | 247 |
|
|
2024
Q4 | $246M | Sell |
3,321,197
-161,211
| -5% | -$12M | 0.09% | 227 |
|
|
2024
Q3 | $239M | Sell |
3,482,408
-1,735,109
| -33% | -$119M | 0.09% | 219 |
|
|
2024
Q2 | $476M | Sell |
5,217,517
-302,340
| -5% | -$27.6M | 0.18% | 122 |
|
|
2024
Q1 | $480M | Sell |
5,519,857
-710,696
| -11% | -$61.8M | 0.21% | 114 |
|
|
2023
Q4 | $473M | Buy |
6,230,553
+318,902
| +5% | +$24.2M | 0.21% | 118 |
|
|
2023
Q3 | $418M | Sell |
5,911,651
-1,498,503
| -20% | -$106M | 0.21% | 116 |
|
|
2023
Q2 | $679M | Buy |
7,410,154
+914,993
| +14% | +$83.9M | 0.34% | 60 |
|
|
2023
Q1 | $542M | Sell |
6,495,161
-1,613,687
| -20% | -$135M | 0.29% | 82 |
|
|
2022
Q4 | $629M | Buy |
8,108,848
+1,673,580
| +26% | +$130M | 0.35% | 66 |
|
|
2022
Q3 | $561M | Buy |
6,435,268
+1,154,632
| +22% | +$101M | 0.33% | 61 |
|
|
2022
Q2 | $511M | Sell |
5,280,636
-47,911
| -0.9% | -$4.64M | 0.41% | 50 |
|
|
2022
Q1 | $658M | Buy |
5,328,547
+881,088
| +20% | +$109M | 0.45% | 42 |
|
|
2021
Q4 | $538M | Sell |
4,447,459
-351,962
| -7% | -$42.6M | 0.34% | 68 |
|
|
2021
Q3 | $543M | Buy |
4,799,421
+29,607
| +0.6% | +$3.35M | 0.38% | 56 |
|
|
2021
Q2 | $494M | Buy |
+4,769,814
| New | +$494M | 0.34% | 61 |
|